Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous C1-esterase Inhibitor in Hereditary Angioedema
NCT01576523Phase 2Completed
- Sponsor
- CSL Limited
- Start
- Apr 2012
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by CSL Limited. Started Apr 2012; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT01576523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576523.